Immatics Aktie
WKN DE: A2P72S / ISIN: NL0015285941
01.10.2025 13:31:07
|
Immatics Appoints Venkat Ramanan As CFO
(RTTNews) - Immatics N.V. (IMTX), a clinical-stage biopharmaceutical company, on Wednesday announced that it has appointed Venkat Ramanan as Chief Financial Officer with immediate effect.
Ramanan will take over from Arnd Christ.
Ramanan brings over 25 years of experience in the biopharmaceutical industry. Ramanan previously served as CFO at Anthos Therapeutics, a Novartis company.
On Tuesday, Immatics closed trading 7.71% higher at $8.52 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Immatics N.V. Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Immatics N.V. Registered Shsmehr Analysen
Aktien in diesem Artikel
Immatics N.V. Registered Shs | 7,31 | -3,69% |
|